"Studies like this strongly suggest that radiologists will be masters of their domain for quite some time," one expert wrote in a corresponding JAMA editorial. 

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

AI technology could be a game-changer for the diagnosis and treatment of sleep disorders, according to a new statement from the American Academy of Sleep Medicine (AASM).

A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.

Brigham and Women’s Hospital physicians have discovered that irregular sleep patterns can significantly hike a person’s risk for heart disease, even if they’re otherwise healthy.

Drugs used to treat opioid use disorder may also be successful in improving the health outcomes of patients admitted to the hospital for injection drug use-associated endocarditis, according to research out of Boston.

The discovery came after researchers combed through hundreds of brain scans and found that nearly 40% of patients did not have the reduced gray matter volumes typically seen in those with the disorder.

TeraRecon announced Monday, March 2, that its AI solutions have been awarded two technology patents from the U.S. Patent and Trademark Office.

HHS is investigating a potential problem with the first round of diagnostics for coronavirus after fears of contamination at a lab where government tests were sent. Timothy Stenzel, an FDA official and scientist who visited the government lab, sounded the alarm after witnessing procedures that concerned him.

The Supreme Court will listen to the legal challenge to the Affordable Care Act that has been working its way through the lower courts. The court made its decision to hear the case Monday, March 2.